Moderna CEO's 9 Words That Could Mean Billions for the Biotech
Moderna (NASDAQ: MRNA) generated revenue of roughly $60 million in 2019. The company will post total revenue measured in the hundreds of millions of dollars for 2020. But the big bucks begin rolling in this year.
Well over 600 million doses of Moderna's COVID-19 vaccine mRNA-1273 will be sold in 2021. Based on its current supply agreements, the company should make around $11.7 billion.
There's been considerable uncertainty, though, about what kind of recurring revenue Moderna could make from mRNA-1273 after this year. But investors now have a reason to be more optimistic about the company's prospects. Nine words uttered by Moderna's CEO Stephane Bancel last week could mean billions for the biotech.
Source Fool.com
